Research / Announcements Projectes de recerca

FOREUM Platinum Call 2025 with UCB


Announcement "open"
caduca en menys de 10 dies I'm interested
Organization:
FOREUM Foundation for Research in Rheumatology, in collaboration with UCB
Scope:
Start:
Internal deadline:
Official deadline:
Amount:
600.000 Euro for a 3-year funding period
Description:

About the funder:
FOREUM Foundation for Research in Rheumatology is a non-profit organization dedicated to promoting research in rheumatic and musculoskeletal diseases (RMDs) across Europe. It aims to foster innovative and collaborative research to improve patient outcomes and advance scientific knowledge in the field.

Call overview:
The FOREUM Platinum Call 2025 is launched in collaboration with UCB, a global biopharmaceutical company focused on neurology and immunology. This call seeks to support high-impact, innovative research projects in the field of rheumatology, particularly those addressing unmet needs in systemic lupus erythematosus (SLE).

The call is designed to fund one large-scale, ambitious project that can deliver transformative outcomes for patients with SLE. The project should be patient-centered, translational, and involve multidisciplinary collaboration. Proposals must demonstrate scientific excellence, innovation, and a clear pathway to impact.

The call follows a two-stage submission process:

  • Stage 1: Letter of Intent (LOI) - a short pre-proposal outlining the concept and objectives.
  • Stage 2: Full Proposal - invited only for selected LOIs.

Objectives of the call:

  • To support transformative research in systemic lupus erythematosus.
  • To foster collaboration between academia, industry, and patient organizations.
  • To promote translational approaches that bridge basic science and clinical application.
  • To improve long-term outcomes and quality of life for patients with SLE.
Requirements

Eligibility criteria are not explicitly detailed in the call text. However, based on FOREUM's general funding principles, applicants are expected to be:

  • Affiliated with academic or non-profit research institutions.
  • Based in Europe or collaborating with European institutions.
  • Able to demonstrate a strong track record in rheumatology research.

Multidisciplinary and international consortia are encouraged. Inclusion of patient representatives and collaboration with industry partners (such as UCB) is considered a strength.

Request

In case of interest, please click on "m'interessa" and we will contact you.

call website